As per Washington state guidance, masks are required regardless of vaccination status in all of our facilities. Please be aware that if you do not have a mask when you arrive we can provide one for you or reschedule your appointment. We appreciate your understanding!

Vidofludimus Calcium

Caldose -1: A phase 2, multicenter, randomized, double-blind, placebo-controlled, dose-finding study to evaluate the efficacy and safety of IMU-838 for induction and maintenance therapy in moderate-to-severe ulcerative colitis

  • Male or female 18 - 80 with UC
  • Mayo score: >/= 2 Stool Freq; >/= 1 Rectal Bleeding; MES >/= 2
  • Biological/Immunomodulator Failed or inadequate response/intolerance/dependent to steroids
  • Induction, Extended Induction, Maintenance, and Open label phases in trial; Up to 10 years
  • Oral Doses: 5mg vs 15mg vs 22.5mg vs placebo; 1:1:1:1. All receive drug in open label phase

If you are interested in participating in clinical studies, please send an email to wagiresearch@washgi.com.

17 Locations Focused on Serving Your Needs

Email us at [email protected]